
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Cell Dev. Biol. , 20 July 2023
Sec. Molecular and Cellular Pathology
Volume 11 - 2023 | https://doi.org/10.3389/fcell.2023.1244890
This article is a correction to:
USP14 as a Therapeutic Target Against Neurodegeneration: A Rat Brain Perspective
A Corrigendum on
USP14 as a therapeutic target against neurodegeneration: a rat brain perspective
by Banerjee C, Roy M, Mondal R and Chakraborty J (2020). Front. Cell Dev. Biol. 8:727. doi: 10.3389/fcell.2020.00727
In the published article, there was an error in affiliation 3. Instead of “Academy of Scientific and Innovative Research (AcSIR), CSIR- Human Resource Development Centre, Ghaziabad, India”, it should be “Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: USP14, Prohibitin2, mitophagy, neurodegeneration, Parkinson’s disease, substantia nigra, rotenone, 3-nitropropionic acid
Citation: Banerjee C, Roy M, Mondal R and Chakraborty J (2023) Corrigendum: USP14 as a therapeutic target against neurodegeneration: a rat brain perspective. Front. Cell Dev. Biol. 11:1244890. doi: 10.3389/fcell.2023.1244890
Received: 13 July 2023; Accepted: 13 July 2023;
Published: 20 July 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Banerjee, Roy, Mondal and Chakraborty. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Joy Chakraborty, am95LmNoYWtyYWJvcnR5QGlpY2IucmVzLmlu
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.